Duchesnay Inc.   Report issue

For profit Phase 3 Phase 4
Founded: Montreal Canada (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2004
NCT02300155
First Marketed Drug
2013
ospemifene (osphena)
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

DUCHESNAY